POINT Biopharma Global Inc. - FORM S-1 - EX-23.1 - June 15, 2020

Attached files

file filename
EX-10.6 - EX-10.6 - POINT Biopharma Global Inc.a2241874zex-10_6.htm
EX-10.5 - EX-10.5 - POINT Biopharma Global Inc.a2241874zex-10_5.htm
EX-10.4 - EX-10.4 - POINT Biopharma Global Inc.a2241874zex-10_4.htm
EX-10.3 - EX-10.3 - POINT Biopharma Global Inc.a2241874zex-10_3.htm
EX-10.2 - EX-10.2 - POINT Biopharma Global Inc.a2241874zex-10_2.htm
EX-10.1 - EX-10.1 - POINT Biopharma Global Inc.a2241874zex-10_1.htm
EX-5.1 - EX-5.1 - POINT Biopharma Global Inc.a2241874zex-5_1.htm
EX-4.4 - EX-4.4 - POINT Biopharma Global Inc.a2241874zex-4_4.htm
EX-4.3 - EX-4.3 - POINT Biopharma Global Inc.a2241874zex-4_3.htm
EX-4.2 - EX-4.2 - POINT Biopharma Global Inc.a2241874zex-4_2.htm
EX-4.1 - EX-4.1 - POINT Biopharma Global Inc.a2241874zex-4_1.htm
EX-3.3 - EX-3.3 - POINT Biopharma Global Inc.a2241874zex-3_3.htm
EX-3.2 - EX-3.2 - POINT Biopharma Global Inc.a2241874zex-3_2.htm
EX-3.1 - EX-3.1 - POINT Biopharma Global Inc.a2241874zex-3_1.htm
EX-1.1 - EX-1.1 - POINT Biopharma Global Inc.a2241874zex-1_1.htm
S-1 - S-1 - POINT Biopharma Global Inc.a2241874zs-1.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Registration Statement on Form S-1, of our report dated June 15, 2020, relating to the balance sheet of Therapeutics Acquisition Corp. as of April 30, 2020, and the related statements of operations, changes in stockholder’s equity and cash flows for the period from April 15, 2020 (inception) through April 30, 2020, and to the reference to our Firm under the caption “Experts” in the Prospectus.

 

/s/ WithumSmith+Brown, PC

 

 

 

New York, New York

 

June 15, 2020

 


POINT Biopharma Global Inc. Reports